首页> 外国专利> Compounds derived from 1 sulfonyl pyrrolidine; Preparation procedure;Pharmaceutical composition containing such Compounds; and use of the compound for controlling and / or prevent Neurological Disorders, acute and / or chronic Chorea Huntington.Amyotrophic lateral sclerosis, Parkinson's disease, retinopathy, migrana.

Compounds derived from 1 sulfonyl pyrrolidine; Preparation procedure;Pharmaceutical composition containing such Compounds; and use of the compound for controlling and / or prevent Neurological Disorders, acute and / or chronic Chorea Huntington.Amyotrophic lateral sclerosis, Parkinson's disease, retinopathy, migrana.

机译:衍生自1磺酰基吡咯烷的化合物;制备方法;含有此类化合物的药物组合物;以及该化合物在控制和/或预防急性和/或慢性Chorea Huntington神经系统疾病中的用途。肌萎缩性侧索硬化症,帕金森氏病,视网膜病,偏头痛。

摘要

The Invention relates to compounds that can be represented by the General formula wherein R1, R2, R3 and N have the meanings defined in the description.The invencionse further relates to medicaments containing these compounds and Process for obtaining them.The compounds have Affinity with metabotropic glutamate receptors and are therefore useful in the treatment and Prevention of acute Neurological Disorders and / or chronic.
机译:本发明涉及可以由通式表示的化合物,其中R 1,R 2,R 3和N具有说明书中定义的含义。本发明还涉及含有这些化合物的药物及其制备方法。谷氨酸受体,因此可用于治疗和预防急性神经系统疾病和/或慢性疾病。

著录项

  • 公开/公告号CL2001001525A1

    专利类型

  • 公开/公告日2002-04-25

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG.;

    申请/专利号CL2001001525

  • 发明设计人 MUTEL VINCENT WICHMANN JUERGEN;

    申请日2001-06-29

  • 分类号A61K31/40;A61K31/4025;A61P25/00;C07D207/48;C07D249/08;C07D271/06;C07D403/06;C07D413/06;A61K31/4025;A61K31/4025;A61K31/4025;A61K31/4025;

  • 国家 CL

  • 入库时间 2022-08-22 00:45:56

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号